There are too many active and semi-completed trials with Erivedge. This is like being in a casino and playing 20 tables! Any of these trials (specially ones in kids) can have over-the-top results and per FDA rules they have to stop and give treatment to all patients at the effective dose. Great for the patients and good for us!!!!!!
what data are you referring to? cudc 907 might have some data for ash in early dec. and one of the iap trials currently running in ph1 for ovarian is open label so who know what could leak out of there. erivedge operable trial finished and data could drop from roche in october or early '14.